COIS 2025: Focus on Retina!
-
Join your retina colleagues from across Canada for a robust educational update on state-of-the-art imaging technology!
​​​
-
A faculty of preeminent international imaging experts will lead a dynamic and interactive program of panel discussions, debates and group dialogue
​​​
-
Through multi-modal imaging analysis we'll explore anatomical concepts, pathologic correlations, predictive models, imaging biomarkers, artificial intelligence and more…
Venue
​
COIS 2025 is taking place at the Omni King Edward Hotel, Toronto, Ontario
Learning Objectives
Participants in COIS 2025 will have the opportunity to:
​
-
Exchange experiences and new ideas on retinal imaging for diagnosis and treatment plans, with the overall goal of applying new developments to daily practice
​
-
Apply practical clinical decision-making based on image findings
​
-
Review advanced new imaging technologies and their potential advantages and clinical use
​
-
Understand how the development of new imaging modalities has greatly influenced therapeutic choices in the medical and surgical management of retinal pathologies
​
-
Share translational research from Canadian and international experts in the field
Faculty
International Guest Speakers
Co-chairs
Detailed Objectives, by Session:
​Session 1: WORKSHOP – Practice Makes Perfect
Participants will be better able to:
-
Describe the use of state-of-the-science imaging for establishing diagnosis, best treatment, and prognosis of retinal diseases
Session 2: Surgical Management
Participants will be better able to:
-
Understand the clinical rationale for integrating anterior segment imaging into their retina practice
-
Review the principles of adaptive optics, and how it can enhance high-resolution retinal imaging. This modality can be particularly useful for monitoring micro anatomic changes that can occur following gene therapy utilizing viral vectors.
-
Understand how OCT biomarkers can aid in assessing the severity, monitoring recovery, and predicting outcomes with surgical interventions.
Session 3: Medical Retina Treatment - From the Past to the Present
Participants will be better able to:
-
Better understand the origin and validation of the ETDRS as the "gold standard” for functional visual assessment.
-
Assess real-world efficacy and safety data towards informing clinical practice
-
Describe the efficacy and safety data regarding the use of intravitreal anti-VEGF injections in the treatment of CRVO.
Session 4: Multimodal Surgical Imaging and Myopia
Participants will be better able to:
-
Evaluate current imaging modalities of the vitreous and vitreomacular interface, interpret their diagnostic findings, and assess their clinical implications in retinal practice.
-
Consider and evaluate clinical options for optimizing outcomes in submacular hemorrhage. Determine which patients may benefit from intervention.
-
Understand the critical role of various imaging modalities in diagnosing, staging and monitoring ocular cancers.
-
Describe the clinical spectrum of myopic macupothy and optimizing its management.
​
Session 5: Deeper Dives: Disease Exploration
Participants will be better able to:
-
Understand recent advances in choroidal perfusion in AMD
-
Describe clinical entities associated with a thickened choroid
-
Review the anatomic changes in choroidal thickness that develop after exposure to anti-VEGF therapy, and how this can be utilized in the management of central serous chorioretinopathy.
-
Describe the recent changes to the guidelines for Imaging Choriocapillaris with Swept Source OCT A in AMD
Session 6: Imaging Biomarkers: Multimodal Analysis
Participants will be better able to:
-
Understand the differences between AI-assisted clinical and reading centre approaches in evaluating retinal imaging and diagnosing pathology.
-
Evaluate data for OCT and OCT A in predicting angiogenesis triggers in AMD
-
Describe emerging technologies and their impact on future retinal imaging